ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #635Top JournalReview JournalHybrid

Medicinal Research Reviews

Acronym:med
•
Abbreviation (ISO):MED. RES. REV
•
Identifier (ISSN):0198-6325(Print)/1098-1128(Online)
•
Publisher:John Wiley and Sons Inc.
Clarivate IF (2026)
13.6↑ +2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Medicinal Research Reviews

WoS Q1
5914188.2920189.7920199.3202012.9202112.4202213.3202310.9202411.6202513.62026
Annual Impact Factor Metric
Current (2026):13.6
Scopus SJR & RankScopus Q1
3.265
#635

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
167

167 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
72articles/year
29.15% Gold OA•0% Original Research

Aims & Scope

Medicinal Research Reviews publishes timely, critical reviews and opinion-based articles on topics related to medicinal research, broadly defined, to which the authors have made significant contributions. Appropriate topics include, but are not limited to, the underlying pathophysiology of important diseases and disease vectors; therapeutic approaches to the treatment of various diseases; the properties of molecular targets for therapeutic agents; important new methodologies facilitating the search for therapies; genomics and proteomics; structure-activity correlations of drug series; the development of new imaging and diagnostic tools; drug metabolism; drug delivery; and chemical, pharmacological, pharmacokinetic, pharmacodynamic, and clinical characteristics of important drugs. Articles are mainly solicited by the Editors; however, voluntary contributions are also encouraged. In the latter case, potential authors are asked to contact the Editor-in-chief with an outline (see below) before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and the level of coverage.

Topics Covered (Recognized by AI)
MedicineBiologyChemistryBiochemistryGeneticsInternal MedicinePharmacologyOrganic ChemistryPhysicsPsychology
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CHEMISTRY, MEDICINAL

Q1
Rank1/72
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank9/356
IndexSCIE
JCISCIE2026

CHEMISTRY, MEDICINAL

Q1
Rank3/72
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank24/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF13.6
Articles / Year78
Total Citations36
2025
IF11.6
Articles / Year71
Total Citations480
2024
IF10.9
Articles / Year88
Total Citations1,827
2023
IF13.3
Articles / Year89
Total Citations3,378
2022
IF12.388
Articles / Year54
Total Citations2,367

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #635Scopus Q1SCImago Profile
Scopus Coverage:1981-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
3.265

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
14.76

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,043 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,207
3-Year Documents194
Citable Documents193

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate38.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ1
Molecular MedicineQ1
PharmacologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区CHEMISTRY, MEDICINAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Medicinal Research Reviews (acronym: med, abbr: MED. RES. REV, ISSN: 0198-6325) is a peer-reviewed international scholarly journal in the field of Medicine, published by John Wiley and Sons Inc. in United States since 1981. The periodical holds a Journal Impact Factor (JIF) of 13.6, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.265 (Q1), an H-index of 167.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 72 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,043 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
John Wiley and Sons Inc.
Publication Language
English
Frequency
Bimonthly
Founding Year
1981
Indexing & Databases
SCIEScopusPubMed
Editorial Address
JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4a5c01fd-7c39-4826-afdc-c92db3792ac9
Database Updated: 2026-09-28